CRL
Charles River Laboratories International, Inc. (CRL)
NYSE · Healthcare
Charles River Laboratories International, Inc. annual/quarterly revenue history and growth rate from 2008 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Charles River Laboratories International, Inc. revenue for the quarter ending March 28, 2026 was 995.8 M, a 1.18% increase year-over-year.
- Charles River Laboratories International, Inc. revenue for the twelve months ending March 28, 2026 was 4.0 B, a 1.40% decrease year-over-year.
- Charles River Laboratories International, Inc. annual revenue for 2025 was 4.0 B, a 0.85% decrease from 2024.
- Charles River Laboratories International, Inc. annual revenue for 2024 was 4.0 B, a 1.92% decrease from 2023.
- Charles River Laboratories International, Inc. annual revenue for 2023 was 4.1 B, a 3.86% increase from 2022.
- Charles River Laboratories International, Inc. annual revenue for 2022 was 4.0 B.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Charles River Laboratories International, Inc. Market Cap — FAQ
Charles River Laboratories International, Inc. (CRL) market cap over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CRL's market cap history?
The chart and table above show Charles River Laboratories International, Inc.'s market cap by year and by quarter, including the growth rate.